GL1X · GenesisL1 explorer

UniProt O80992

Abscisic acid receptor PYL2 (O80992)

Abscisic acid receptor PYL2 (UniProt O80992): 54 experimental structures and 1 predicted model on GenesisL1, 8 ligands bound, 19 pockets. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.

UniProt
O80992
Protein
Abscisic acid receptor PYL2
Experimental structures
54
Predicted models
1
Ligands
8
Pockets
19 · 7 records with a druggable one

Structures

55 records of O80992 in the MolNFT archive: 54 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
3KAZCrystal structure of abscisic acid receptor PYL2x-ray diffractionA, B, C——
3KAZCrystal structure of abscisic acid receptor PYL2x-ray diffractionA, B, C——
3KB0Crystal structure of abscisic acid-bound PYL2x-ray diffractionA——
3KB0Crystal structure of abscisic acid-bound PYL2x-ray diffractionA——
3KB3Crystal structure of abscisic acid-bound PYL2 in complex with HAB1x-ray diffractionA——
3KB3Crystal structure of abscisic acid-bound PYL2 in complex with HAB1x-ray diffractionA——
3KDHStructure of ligand-free PYL2x-ray diffractionA, B, C——
3KDHStructure of ligand-free PYL2x-ray diffractionA, B, C——
3KDIStructure of (+)-ABA bound PYL2x-ray diffractionA——
3KDIStructure of (+)-aba bound PYL2x-ray diffractionA——
3KL1Crystal structure of abscisic acid receptor PYL2 at 1.55 Ax-ray diffractionA, B——
3KL1Crystal structure of abscisic acid receptor PYL2 at 1.55 ax-ray diffractionA, B——
3NJ0X-ray crystal structure of the PYL2-pyrabactin A complexx-ray diffractionA, B, C——
3NJ0X-ray crystal structure of the PYL2-pyrabactin a complexx-ray diffractionA, B, C——
3NJ1X-ray crystal structure of the PYL2(V114I)-pyrabactin A complexx-ray diffractionA——
3NJ1X-ray crystal structure of the PYL2(V114I)-pyrabactin a complexx-ray diffractionA——
3NMHCrystal structure of the abscisic receptor PYL2 in complex with pyrabactinx-ray diffractionA, B, C——
3NMHCrystal structure of the abscisic receptor PYL2 in complex with pyrabactinx-ray diffractionA, B, C——
3NMPCrystal structure of the abscisic receptor PYL2 mutant A93F in complex with pyrabactinx-ray diffractionA, B, C——
3NMPCrystal structure of the abscisic receptor PYL2 mutant A93F in complex with pyrabactinx-ray diffractionA, B, C——
3NMTCrystal structure of pyrabactin bound abscisic acid receptor PYL2 mutant A93F in complex with type…x-ray diffractionA——
3NMTCrystal structure of pyrabactin bound abscisic acid receptor PYL2 mutant A93F in complex with type…x-ray diffractionA——
3NMVCrystal structure of pyrabactin-bound abscisic acid receptor PYL2 mutant A93F in complex with type…x-ray diffractionA——
3NMVCrystal structure of pyrabactin-bound abscisic acid receptor PYL2 mutant A93F in complex with type…x-ray diffractionA——
3NR4Pyrabactin-bound PYL2x-ray diffractionA, B, C——
3NR4Pyrabactin-bound PYL2x-ray diffractionA, B, C——
3NS2High-resolution structure of pyrabactin-bound PYL2x-ray diffractionA, B, C——
3NS2High-resolution structure of pyrabactin-bound PYL2x-ray diffractionA, B, C——
3UJLCrystal structure of abscisic acid bound PYL2 in complex with type 2C protein phosphatase ABI2x-ray diffractionA——
3UJLCrystal structure of abscisic acid bound PYL2 in complex with type 2C protein phosphatase ABI2x-ray diffractionA——
4LA7X-ray crystal structure of the PYL2-quinabactin-Hab1 ternary complexx-ray diffractionA——
4LA7X-ray crystal structure of the PYL2-quinabactin-HAB1 ternary complexx-ray diffractionA——
4LG5ABA-mimicking ligand QUINABACTIN in complex with ABA receptor PYL2 and PP2C HAB1x-ray diffractionA——
4LG5Aba-mimicking ligand quinabactin in complex with aba receptor PYL2 and PP2C HAB1x-ray diffractionA——
4LGAABA-mimicking ligand N-(2-OXO-1-PROPYL-1,2,3,4-TETRAHYDROQUINOLIN-6-YL)-1-PHENYLMETHANESULFONAMIDE…x-ray diffractionA——
4LGAAba-mimicking ligand N-(2-oxo-1-propyl-1,2,3,4-tetrahydroquinolin-6- yl)-1-phenylmethanesulfonamide…x-ray diffractionA——
4LGBABA-mimicking ligand N-(1-METHYL-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-6-YL)-1-(4-METHYLPHENYL)METHANESUL…x-ray diffractionA——
4LGBAba-mimicking ligand N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-6…x-ray diffractionA——
5JNNCrystal structure of abscisic acid receptor PYL2 in complex with Phaseic acid.x-ray diffractionA6LM1 (best 0.82)
5JNNCrystal structure of abscisic acid receptor PYL2 in complex with phaseic acid.x-ray diffractionA——
5VR7ABA-mimicking ligand AMF1alpha in complex with ABA receptor PYL2 and PP2C HAB1x-ray diffractionAA1F—
5VR7Aba-mimicking ligand AMF1ALPHA in complex with aba receptor PYL2 and PP2C HAB1x-ray diffractionAA1F—
5VROABA-mimicking ligand AMF1beta in complex with ABA receptor PYL2 and PP2C HAB1x-ray diffractionAA7S3 (best 0.86)
5VROAba-mimicking ligand AMF1BETA in complex with aba receptor PYL2 and PP2C HAB1x-ray diffractionAA7S—
5VS5ABA-mimicking ligand AMF2alpha in complex with ABA receptor PYL2 and PP2C HAB1x-ray diffractionA9J73 (best 0.85)
5VS5Aba-mimicking ligand AMF2ALPHA in complex with aba receptor PYL2 and PP2C HAB1x-ray diffractionA9J7—
5VSQABA-mimicking ligand AMF2beta in complex with ABA receptor PYL2 and PP2C HAB1x-ray diffractionAA2V—
5VSQAba-mimicking ligand AMF2BETA in complex with aba receptor PYL2 and PP2C HAB1x-ray diffractionAA2V—
5VSRABA-mimicking ligand AMF4 in complex with ABA receptor PYL2 and PP2C HAB1x-ray diffractionAAF04 (best 0.86)
5VSRAba-mimicking ligand AMF4 in complex with aba receptor PYL2 and PP2C HAB1x-ray diffractionAAF0—
5VT7ABA-mimicking ligand AMC1beta in complex with ABA receptor PYL2 and PP2C HAB1x-ray diffractionAA1C3 (best 0.86)
5VT7Aba-mimicking ligand AMC1BETA in complex with aba receptor PYL2 and PP2C HAB1x-ray diffractionAA1C—
7MWNAn engineered PYL2-based WIN 55,212-2 synthetic cannabinoid sensor with a stabilized HAB1 variantx-ray diffractionAWI53 (best 0.86)
7MWNAn engineered PYL2-based win 55,212-2 synthetic cannabinoid sensor with a stabilized HAB1 variantx-ray diffractionAWI5—
O80992AlphaFold monomer V2.0 prediction for abscisic acid receptor PYL2 (O80992)predictedA—2 (best 0.77)

Ligands

  • 9J7 · 1-(2,3-difluoro-4-methylphenyl)-N-(2-oxo-1-propyl-1,2, 3,4-tetrahydroquinolin-6-yl)methanesulfonamide · in 2 records
  • A1C · 1-(3-chloro-4-methylphenyl)-N-(2-oxo-1-propyl-1,2,3,4-tetrahydroquinolin-6-yl)methanesulfonamide · in 2 records
  • A1F · 1-(2-fluoro-4-methylphenyl)-N-(2-oxo-1-propyl-1,2,3,4-tetrahydroquinolin-6-yl)methanesulfonamide · in 2 records
  • A2V · 1-(3,5-difluoro-4-methylphenyl)-N-(2-oxo-1-propyl-1,2, 3,4-tetrahydroquinolin-6-yl)methanesulfonamide · in 2 records
  • A7S · 1-(3-fluoro-4-methylphenyl)-N-(2-oxo-1-propyl-1,2,3,4-tetrahydroquinolin-6-yl)methanesulfonamide · in 2 records
  • AF0 · N-(2-oxo-1-propyl-1,2,3,4-tetrahydroquinolin-6-yl)-1-(2,3,5,6-tetrafluoro-4-methylphenyl)methanesulfonamide · in 2 records
  • WI5 · {(3R)-5-methyl-3-[(morpholin-4-yl)methyl]-2,3-dihydro[1,4]oxazino[2,3,4-hi]indol-6-yl}(naphthalen-1-yl)methanone · in 2 records
  • 6LM · (3S,4E)-5-[(1R,5R,8S)-8-hydroxy-1,5-dimethyl-3-oxo-6-oxabicyclo[3.2.1]octan-8-yl]-3-methylpent-4-enoic acid · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.